Proponent case report by an oncology/radiotherapy specialist describing ENS/SCENAR/COSMODIC treatment alongside prior hormone therapy and chemotherapy in inoperable prostate cancer, with PSA and symptom claims.
SCENAR Therapy / Neuro-Adaptive Electrostimulation
SCENAR Therapy / Neuro-Adaptive Electrostimulation is a device-based, energetic, or frequency-oriented protocol discussed in alternative cancer circles for pain, energy, inflammation, scar work, immune signaling, detoxification, or direct anticancer frequency claims. In cancer care, it should be evaluated by evidence level, intended use, safety, interactions, and whether it is being used as conventional treatment, supportive care, an experimental adjunct.
PubMed record for the 2021 randomized single-blinded SCENAR low-back/neck pain trial, concluding one session was not better than sham.
Randomized single-blinded sham trial in 60 low-back/neck pain patients; pain decreased in both active and sham groups with no significant between-group advantage and no durable next-day benefit.
Randomized double-blind fibromyalgia trial of 37 women; active neuro-adaptive electrostimulation improved pain and quality of life at 4 weeks compared with sham, but authors called for larger studies.
Google Books listing for Peter H. Lathrop book with cover and metadata; presents SCENAR for neuromuscular injuries and spinal-cord regeneration claims.
Proponent tutorial stating there are no absolute contraindications and that SCENAR can be applied in oncological disorders, while listing relative cautions such as pacemakers and acute infections with unclear diagnosis.
RITM company history noting Cosmonaut Training Center interest and a 1986 SCENAR development contract with a mailbox organization likely connected to the USSR Space Agency.
Manufacturer history page describing late-1970s prototype work, 1986 Ministry of Health presentation, 1987/1989 authorship certificates, and early developers.
Training/academy page describing SCENAR development under Alexander Revenko and others for treating cosmonauts in space.
Proponent indications page making broad claims across body systems and stating SCENAR is used in oncology, reanimation, and urgent therapy.
Professional product page listing pain-related indications, postoperative analgesia contexts, and contraindications similar to Sport D.
LET Medical page describing Alexander Karasev, SCENAR/COSMODIC technologies, patents, and official medical-use history.
FAQ listing contraindications including implanted electrical devices, alcohol intoxication, electric-stimulation intolerance, and acute infectious disease with unclarified diagnosis; also states restrictions reflect lack of necessary research.
U.S. distributor page marketing RITMSCENAR electrotherapy products for physical therapy and drug-free pain management.
Clinic page saying SCENAR was developed in Taganrog under Alexander Revenko and others for treating cosmonauts in space; claims few contraindications.
Commercial/proponent page claiming SCENAR was developed for Soviet spacecraft and describing pain-relief and broad disease claims.
Product page listing pain-related indications and contraindications including hypersensitization/pregnancy, pacemaker, alcohol intoxication, and acute infectious diseases.
RITMSCENAR USA support page describing itself as American office of RITM OKB ZAO and pointing to FDA classification/support resources.
Manufacturer page defining SCENAR as self-controlled energy-neuroadaptive regulator and noting most non-Russian regulatory certification is for pain relief.